Impact of beta blocker administration on outcome among patients undergoing transcatheter aortic valve replacement - B-TAVR

Conditions

Aortic stenosis

Brief summary

Composite endpoint of all-cause mortality, rehospitalization due to heart failure, stroke, severe arrhythmia (new onset atrial fibrillation/flutter, ventricular tachycardia/ventricular fibrillation, new high-grade AV-Block) at 30 days

Detailed description

Pacemaker Rate at 30 days and at 1 year, Stroke Rate at 30 days and at 1 year, All-cause mortality at 30 days and 1 year, Cardiovascular mortality at 30 days and 1 year, Re-hospitalization due to heart failure at 30 days and 1 year, Severe arrhythmia requiring treatment (e.g.: new onset atrial fibrillation/flutter, ventricular tachycardia /ventricular fibrillation, new AV Block (I, II or III), new left bundle branch block, new right bundle branch block, intraventricular conduction delay (QRS ≥120ms), new severe bradycardia (HR <60 bpm) requiring treatment or tachycardia (‹40bpm or ›120bpm), sick sinus syndrome, new tachycardia (HR>120 bpm) at 30 days and at 1 year

Related papers

No related papers found yet.

Interventions

DRUG-

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Composite endpoint of all-cause mortality, rehospitalization due to heart failure, stroke, severe arrhythmia (new onset atrial fibrillation/flutter, ventricular tachycardia/ventricular fibrillation, new high-grade AV-Block) at 30 days	—

Secondary

Measure	Time frame
Pacemaker Rate at 30 days and at 1 year, Stroke Rate at 30 days and at 1 year, All-cause mortality at 30 days and 1 year, Cardiovascular mortality at 30 days and 1 year, Re-hospitalization due to heart failure at 30 days and 1 year, Severe arrhythmia requiring treatment (e.g.: new onset atrial fibrillation/flutter, ventricular tachycardia /ventricular fibrillation, new AV Block (I, II or III), new left bundle branch block, new right bundle branch block, intraventricular conduction delay (QRS ≥120ms), new severe bradycardia (HR <60 bpm) requiring treatment or tachycardia (‹40bpm or ›120bpm), sick sinus syndrome, new tachycardia (HR>120 bpm) at 30 days and at 1 year	—

Measure

Time frame

Pacemaker Rate at 30 days and at 1 year, Stroke Rate at 30 days and at 1 year, All-cause mortality at 30 days and 1 year, Cardiovascular mortality at 30 days and 1 year, Re-hospitalization due to heart failure at 30 days and 1 year, Severe arrhythmia requiring treatment (e.g.: new onset atrial fibrillation/flutter, ventricular tachycardia /ventricular fibrillation, new AV Block (I, II or III), new left bundle branch block, new right bundle branch block, intraventricular conduction delay (QRS ≥120ms), new severe bradycardia (HR <60 bpm) requiring treatment or tachycardia (‹40bpm or ›120bpm), sick sinus syndrome, new tachycardia (HR>120 bpm) at 30 days and at 1 year

—

Countries

Austria, Germany

Outcome results

None listed